OXALIPLATIN, IRINOTECAN, BEVACIZUMAB FOLLOWED BY DOCETAXEL, BEVACIZUMAB IN INOPERABLE GASTRIC CANCER. A MULTICENTER PHASE II TRIAL (AGMT GASTRIC-3) OF THE ARBEITSGEMEINSCHAFT MEDIKAMENToSE TUMORTHERAPIE (AGMT)

被引：0
|
作者：
Woell, E. [1 ]
Keil, F. [2 ]
Thaler, J. [3 ]
Gruenberger, B. [4 ]
Hejna, M. [5 ]
Eisterer, W. [6 ]
Fridrik, M. A. [7 ]
Romeder, F. [8 ]
Greil, R. [8 ]
机构：
[1] St Vinzenz Krankenhaus Zams, Zams, Austria
[2] Hanusch Hosp, Vienna, Austria
[3] Klinikum Wels Grieskirchen, Wels, Austria
[4] Krankenhaus Barmherzigen Br, Vienna, Austria
[5] Med Univ Vienna, Vienna, Austria
[6] Univ Innsbruck Hosp, Dept Internal Med, A-6020 Innsbruck, Austria
[7] Allgemeines Krankenhaus Linz, Linz, Austria
[8] Univ Hosp Salzburg, Salzburg, Austria
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：249 / 250
页数：2
相关论文
共 50 条
  • [1] Oxaliplatin, irinotecan, bevacizumab followed by docetaxel, bevacizumab in inoperable gastric cancer: Final efficacy results of a multicenter phase II trial (AGMT Gastric-3) of the arbeitsgemeinschaft Medikamentose tumortherapie (AGMT).
    Woell, Ewald
    Keil, Felix
    Thaler, Josef
    Gruenberger, Birgit
    Hejna, Michael
    Eisterer, Wolfgang
    Fridrik, Michael A.
    Romeder, Franz
    Greil, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [2] Oxaliplatin, irinotecan, bevacizumab followed by docetaxel, bevacizumab in inoperable gastric cancer: First efficacy results of a multicenter phase II trial (AGMT Gastric-3) of the Arbeitsgemeinschaft Medikamentose Tumortherapie
    Woell, Ewald
    Thaler, Josef
    Keil, Felix
    Eisterer, Wolfgang
    Fridrik, Michael A.
    Gruenberger, Birgit
    Hejna, Michael
    Romeder, Franz
    Greil, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Oxaliplatin, irinotecan, and bevacizumab followed by docetaxel and bevacizumab in inoperable gastric cancer: First results of a multicenter phase II trial (AGMT Gastric-3) of the Arbeitsgemeinschaft Medikamentoese Tumortherapie (AGMT)
    Woell, E.
    Keil, F.
    Thaler, J.
    Gruenberger, B.
    Hejna, M.
    Eisterer, W.
    Fridrik, M. A.
    Romeder, F.
    Greil, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [4] Oxaliplatin, Irinotecan and Cetuximab in Advanced Gastric Cancer. A Multicenter Phase II Trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT)
    Woell, Ewald
    Greil, Richard
    Eisterer, Wolfgang
    Bechter, Oliver
    Fridrik, Michael A.
    Gruenberger, Birgit
    Zabernigg, August
    Mayrbaeurl, Beate
    Russ, Gudrun
    Dlaska, Margit
    Obrist, Peter
    Thaler, Josef
    [J]. ANTICANCER RESEARCH, 2011, 31 (12) : 4439 - 4443
  • [5] Biweekly Oxaliplatin and Irinotecan Chemotherapy in Advanced Gastric Cancer. A First-line Multicenter Phase II Trial of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT)
    Woell, E.
    Kuehr, T.
    Eisterer, W.
    Gattringer, K.
    Greil, R.
    Zabernigg, A.
    Hilbe, W.
    Thaler, J.
    [J]. ANTICANCER RESEARCH, 2008, 28 (5B) : 2901 - 2905
  • [6] Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3
    Woell, Ewald
    Thaler, Josef
    Keil, Felix
    Gruenberger, Birgit
    Hejna, Michael
    Eisterer, Wolfgang
    Fridrik, Michael A.
    Ulmer, Hanno
    Trommet, Vera
    Huemer, Florian
    Weiss, Lukas
    Greil, Richard
    [J]. ANTICANCER RESEARCH, 2017, 37 (10) : 5553 - 5558
  • [7] Oxaliplatin, irinotecan, and cetuximab in advanced gastric cancer. First efficacy results of a multicenter phase II trial (AGMT Gastric-2) of the Arbeitsgemeinschaft Medikamentoese Tumortherapie (AGMT)
    Woell, E.
    Greil, R.
    Eisterer, W.
    Fridrik, M.
    Gruenberger, B.
    Zabernigg, A.
    Mayrbaeurl, B.
    Russ, G.
    Thaler, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer: First results of a multicenter phase II trial (AGMT Gastric-2
    Woell, E.
    Greil, R.
    Eisterer, W.
    Fridrik, M.
    Gruenberger, B.
    Gattringer, K.
    Mayrbaeurl, B.
    Russ, G.
    Thaler, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Oxaliplatin and Irinotecan in advanced gastric cancer.: A multicenter phase II trial
    Woell, E.
    Eisterer, W.
    Hilbe, W.
    Kuehr, T.
    Gattringer, K.
    Greil, R.
    Zabernigg, A.
    Baldinger, C.
    Thaler, J.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 213 - 213
  • [10] A phase II study of bevacizumab, docetaxel, and oxaliplatin in gastric and GEJ cancer
    El-Rayes, B. F.
    Patel, B.
    Zalupski, M.
    Hammad, N.
    Shields, A.
    Heilbrun, L.
    Venkatramanamoorthy, R.
    Philip, P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345